TrialJournal of immunology (Baltimore, Md. : 1950)2023

Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.

Benjamin G Vincent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.